Received Jun 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | OT |
vaccination site bruising; local pain at the injection site; vaccination site swelling; erythema proximal to the injection site; This Spontaneous report was received from Physician and referred to a/an ( Race Unknown ) ( Ethnicity Unknown) Male patient of unknown age. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On an unknown date, patient started therapy with Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 (0.50 mL) (total) Asked But Unknown Batch/Lot Number dose form was Injection via Intramuscular. The patient started therapy with Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 for the treatment of Pneumonia vaccine, On an unknown date, the patient experienced local pain at the injection site (Vaccination site pain). On an unknown date, the patient experienced vaccination site swelling (Vaccination site swelling). On an unknown date, the patient experienced vaccination site bruising (Vaccination site bruising). On an unknown date, the patient experienced erythema proximal to the injection site (Vaccination site erythema). Site Narrative: the patient was just under 65 years old, male, noting an extreme local reaction with significant bruising and swelling at the site, with extreme erythema proximal to the injection site. Complaint was also made by the patient that there was local pain at the injection site. The patient Sought Medical Attention. The Outcome of Vaccination site bruising was not provided. The Outcome of Vaccination site pain was not provided. The Outcome of Vaccination site swelling was not provided. The Outcome of Vaccination site erythema was not provided. The action taken with Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 regarding Vaccination site bruising was Not applicable with Not Applicable dechallenge and rechallenge results. Case Assessments: Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 regarding Vaccination site pain with Not Applicable dechallenge and rechallenge results. Case Assessments: Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 regarding Vaccination site erythema with Not Applicable dechallenge and rechallenge results. Case Assessments: Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 regarding Vaccination site swelling with Not Applicable dechallenge and rechallenge results. The Physician considered the causality for the event Vaccination site pain to Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 was not reported,, the causality for the event Vaccination site erythema to Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 was not reported,, the causality for the event Vaccination site bruising to Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 was not reported,, and the causality for the event Vaccination site swelling to Pneumococcal 21-valent Conjugate Vaccine Solution for injection 114412038:4347 was not reported, The Physician considered the event Vaccination site pain to be non-serious, the event Vaccination site swelling to be non-serious, the event Vaccination site bruising to be non-serious, and the event Vaccination site erythema to be non-serious